Current Clinical Urology Management of Benign Prostatic Hypertrophy Kartoniert (TB)

A concise up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies as well as time-tested surgical treatments and review the medical therapies for BPH namely a-adrenergic antagonists 5-a reductase inhibitors and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH its epidemiology and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking soun d guidance on the best approach to his patients.